MedTrace Logo

Gabapentin Pretreatment for Staged Bilateral Cataract Operations

NCT03826615 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2020-11-12

No results posted yet for this study

Summary

To evaluate the effect of oral gabapentin premedication on hyperalgesia in elderly patients undergoing staged bilateral cataract operations under monitored anesthesia care

Conditions

  • Hyperalgesia
  • Cataract Bilateral Nos

Interventions

DRUG

Gabapentin

Patients receive gabapentin 100mg orally for 3 times a day during the period of first and second cataract operations

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeong-Hwa Seo, MD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-01-03
Completion
2020-01-03

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826615 on ClinicalTrials.gov